The present study was performed to compare serum concentrations of maternal and fetal angiogenic growth factors in IUGR (intrauterine growth restriction) and normal pregnancy at the time of delivery. VEGF (vascular endothelial growth factor), PlGF (placental growth factor), sFlt-1 (soluble fms-like tyrosine kinase 1), sKDR (soluble kinase domain receptor) and bFGF (basic fibroblast growth factor) were measured by ELISA in serum from a maternal peripheral vein, the umbilical vein and the umbilical arteries in 15 women with pregnancies complicated by IUGR and 16 controls (women with normal pregnancies). In IUGR, sFlt-1 was increased, and PlGF and sKDR were decreased, in both maternal serum and serum from the umbilical vein. Additionally, bFGF was increased in serum from the umbilical vein of women with pregnancies complicated by IUGR. No significant differences in growth factor concentrations between the groups were found in serum from the umbilical artery. In both groups, levels of VEGF were higher and levels of sFlt-1 were lower in serum from the umbilical vein and umbilical artery compared with maternal serum. PlGF levels were found to be lower in serum from the umbilical vein compared with maternal serum in both groups, whereas PlGF levels in serum from the umbilical artery were significantly lower only in the control group. These findings suggest an imbalance of angiogenic and anti-angiogenic factors in IUGR, with formation of an anti-angiogenic state in maternal and, to a lesser extent, umbilical vein blood. The placenta appears to play a central role in the release of sFlt-1 into maternal and umbilical blood. Umbilical artery blood was unaffected in IUGR, indicating that the fetus does not contribute to changes in angiogenic growth factor concentrations.
INTRODUCTION
IUGR (intrauterine growth restriction) is considered a severe complication in pregnancy leading to increased perinatal mortality as well as morbidity [1] . Among the various causes contributing to the development of IUGR, inappropriate placentation is a primary one. Placental development can be divided into vasculogenesis, in which an initial vascular network is formed, and angiogenesis, in which the network is remodelled. Additional blood vessels are generated by sprouting, branching and differential growth of the initial vessels to form a more mature system with larger and smaller vessels [2] .
As angiogenesis and vascular transformation are important in normal placental development, IUGR is thought to result from impaired trophoblast invasion of the maternal spiral arteries in early pregnancy, leading to reduced uteroplacental perfusion and placental hypoxia [3] . It has been hypothesized that placental hypoxia may stimulate the release of factors by the placenta which cause widespread maternal endothelial cell damage and derangement of placental angiogenesis [4] .
What causes the deficient trophoblast invasion remains unknown. There are strong indications that angiogenic growth factors related to VEGF (vascular endothelial growth factor) may be implicated. From bFGF (basic fibroblast growth factor) and VEGF, the study of angiogenesis has expanded to include many additional agonists, receptors and inhibitors, especially PlGF (placental growth factor) and its soluble receptor sFlt-1 (soluble fms-like tyrosine kinase 1) [2, [5] [6] [7] .
To date, studies have focused predominantly on single angiogenic growth factors in the maternal compartment [8] [9] [10] [11] [12] [13] [14] [15] . The aim of the present study was to investigate concentrations of angiogenic growth factors related to VEGF in maternal, placental and fetal compartments and to compare levels in normal pregnancies and pregnancies complicated by IUGR. We hypothesized that maternal and fetal levels of angiogenic growth factors are altered in pregnancies complicated by isolated IUGR.
MATERIALS AND METHODS
Patients were recruited from the perinatal and labour ward of the University of Erlangen-Nuremberg. Women in whom IUGR was suspected by means of ultrasound examinations (abdominal circumference below the fifth centile) were asked to participate in the study. Postnatal IUGR was defined as birth weight below the tenth centile corrected for gestational age [16] . We finally included into the study 15 women with pregnancies complicated by idiopathic IUGR with no signs of pre-existing or pregnancy-induced hypertension or pre-eclampsia {accord-ing to the ISSHP (International Society for the Study of Hypertension in Pregnancy) criteria [17] } with postnatally confirmed IUGR. No other risk factors associated with IUGR were obvious. Fetuses with chromosomal or structural anomalies were excluded from the study. For controls, we selected 16 healthy normotensive pregnant women with singleton pregnancies. To avoid a possible hypoxic effect of labour on angiogenic growth factors, we only selected women who delivered by Caesarean section without labour; women who went into labour or successfully delivered vaginally were excluded from the final analysis. Indications for Caesarean delivery were IUGR and worsening of Doppler parameters or cardiotocography recordings in the IUGR and control groups prior Caesarean section, or breech presentation.
The study was approved by the Ethical Committee at the University of Erlangen-Nuremberg, and informed written consent was obtained from all study subjects.
Maternal venous blood samples were collected from the antecubital vein prior to Caesarean section. Fetal blood samples were taken from the umbilical arteries and vein separately immediately after delivery of the placenta. All blood samples were centrifuged immediately after collection at 2500 g for 15 min at 4
• C, and serum was aliquoted and stored at − 80
• C until measurement (maximal length of storage 21 months).
Serum bFGF, VEGF, PlGF and sFlt-1 levels were measured in all three compartments [maternal (antecubital vein), placental (umbilical vein) and fetal (umbilical arteries)]. sKDR (soluble kinase domain receptor) was measured only in maternal serum and serum from the umbilical vein. All factors were measured by means of quantitative sandwich immunoassay techniques, according to the manufacturer's instructions (R&D Systems). According to the manufacturer, mean minimal detectable doses are: 9 pg/ml for VEGF, 7 pg/ml for PlGF, 5.01 pg/ ml for sFlt-1, 4.6 pg/ml for sKDR and 0.22 pg/ml for bFGF. The ratio of sFlt-1/PlGF was computed using the formula [log (sFlt-1/PlGF × 10)] described by Buhimschi et al. [18] .
In all women, proteinuria was estimated by dipstick analysis, and none of the women included had significant proteinuria. BP (blood pressure) was measured several times throughout the pregnancy until Caesarean section. For estimation of DBP (diastolic BP), Korotkoff V was used according to ISSHP guidelines. MABP (mean arterial BP) was calculated as follows: [mean SBP (mmHg) + 2 × mean DBP (mmHg)]/3, where SBP is systolic BP.
Pulsed Doppler ultrasonic recordings from the umbilical artery were made with a 60-Hz filter, and absent or abnormal end-diastolic blood flow velocity was documented from a minimum of five consecutive waveforms. Abnormal end-diastolic blood flow was defined as a PI (pulsatility index; peak sytolic flow−end-diastolic flow/mean flow) > 95th centile. Uterine arteries were examined similarly. The mean of both uterine arteries was calculated and used for statistical analysis. During the sonographic examination, the amniotic fluid was diagnosed subjectively as being either normal or decreased (oligohydramnios). In women with pregnancies complicated by IUGR, Doppler ultrasound was performed daily, whereas this was performed on the day of admission for delivery in control women.
All analyses were conducted using the statistical software program GraphPad PRISM 4.03 for Windows. Test results are expressed as means + − S.D. Data were tested for normal distribution. Demographic and clinical data were compared by means of independent-samples Student's t tests or Fisher's exact test, as appropriate. Fetal weight and placental centiles were compared by means of the Mann-Whitney test. Comparison of angiogenic growth factors between both groups were done by means of independent-samples Student's t tests or Mann-Whitney test, as appropriate. Comparisons of angiogenic growth factors between the compartments (maternal, placental and fetal) were performed using oneway ANOVA, followed by Bonferroni's multiple comparison test, or Kruskal-Wallis test, followed by Dunn's multiple comparison test, as appropriate. A two-sided P value of < 0.05 was considered statistically significant.
RESULTS

Patient characteristics
The characteristics of the study patients are shown in Table 1 . There were no significant differences between the groups with regard to maternal age, smoking, proteinuria and BP. Owing to the study design (all women had to deliver by Caesarean section without any sign of labour, therefore more women scheduled for repeated Caesarean section were included in the control group), the proportion of primigravid and primiparous women was not significantly lower in the control group. Additionally, the number of primiparous women was higher in the IUGR group, but did not reach statistical significance. Maternal BMI (body mass index) was lower in the IUGR group (P = 0.027) as were gestational age at delivery, fetal birth weight centile and placental weight (P < 0.0001). No difference was found in the fetal/placental ratio (results not shown). PIs in the umbilical artery (P < 0.0001) and uterine arteries (mean of both uterine arteries; P = 0.0056) were significantly higher in the IUGR group compared with the control group.
Angiogenic growth factors
Levels of angiogenic growth factors are shown in Table 2 . In both the control women and women with pregnancies complicated by IUGR, maternal serum VEGF levels were below the detection limit of the assay used. No differences between the groups were observed in maternal serum bFGF concentrations. In the IUGR group, levels of PlGF (P = 0.0017) and sKDR (P = 0.0071) were significantly decreased in maternal serum, whereas sFlt-1 levels were significantly increased (P = 0.0086). Similar differences were observed for umbilical vein serum levels of PlGF (P = 0.0016), sKDR (P = 0.0003) and sFlt-1 (P = 0.0183), but there were no significant differences in these growth factors in umbilical artery serum. As sFlt-1 is thought to act by binding free PlGF and VEGF was below detectable limits, we calculated the ratio of sFlt-1/PlGF [log (sFlt-1/PlGF × 10)]. In IUGR, this ratio was significantly increased (P < 0.0001) in maternal and umbilical vein serum (Figure 1 ). Umbilical vein serum levels of bFGF were significantly higher in the IUGR group (P = 0.0096) than controls.
Comparison of angiogenic growth factors between the compartments is shown in Table 3 . In the control group, 
Figure 1 Ratio of sFlt-1 and free PlGF in control and IUGR groups
The ratio of sFlt-1/PlGF was computed using the formula described by Buhimschi et al. [18] . Horizontal lines indicate the mean values. CTR, control group; mat, maternal; UV, umbilical vein. levels of VEGF were significantly higher (P = 0.001), and sFlt-1 and PlGF were significantly lower (P = 0.001) in both umbilical artery and vein serum compared with maternal serum. bFGF was found to be elevated in umbilical artery serum compared with umbilical vein and maternal serum (P = 0.001). There were no differences in sKDR levels between maternal and umbilical vein serum.
Within the IUGR group, levels of VEGF were significantly higher in umbilical artery and vein serum compared with maternal serum (P = 0.001). PlGF was lower in umbilical vein serum than in maternal serum (P = 0.001). sFlt-1 was significantly lower (P = 0.001) in umbilical artery serum than in maternal serum. There were no differences in sKDR and bFGF levels.
DISCUSSION
Angiogenic growth factors play a crucial role in the normal development of the placenta. The activity of these molecules must be carefully orchestrated in order to form a functioning vascular network. In the present study, we found that angiogenic growth factors of the VEGF family are altered in maternal and fetal serum from pregnancies complicated by IUGR. Furthermore, we observed significant correlations between growth factor levels and various clinical parameters indicating the severity of IUGR.
Owing to the study design, we could not include normotensive women at earlier gestational ages similar to those of the women with pregnancies complicated by IUGR. The difference in gestational age between the groups may affect the levels of angiogenic factors observed; however, according to published findings [10, [19] [20] [21] , levels in control women would be expected to be even higher (PlGF or sKDR) or lower (sFlt-1), and thus the differences would be expected to be even greater at gestational ages corresponding to those of women in the IUGR group. Only differences in bFGF levels might have been missed, because levels in pregnancies complicated by IUGR could actually be significantly lower compared with samples from matched gestational age. Maternal VEGF levels were below the limit of detection, which could be due to the assay used as it only determines free VEGF levels and does not reflect VEGF bound to sFlt-1 [22] . Maternal free VEGF levels were significantly lower than fetal levels, as reported by Vuorela-Vepsäläinen et al. [23] .
Maternal PlGF concentrations were significantly decreased in IUGR, which has been reported previously by several groups [10, [12] [13] [14] 24] . In addition, our results on PlGF levels in healthy pregnant women are consistent with levels published previously [19] . As PlGF originates mostly from the placenta, the reduced placental size observed in IUGR can, in part, explain the decreased PlGF levels in our IUGR group, but, as PlGF is bound by sFlt-1, the increased sFlt-1 levels found in the IUGR group compared with the control group may be primarily responsible for the diminished PlGF levels.
Significantly increased sFlt-1 levels and simultaneously reduced PlGF levels in the blood of women who deliver a growth-restricted infant confirm the current hypothesis that high levels of sFlt-1 bind free PlGF, causing decreased PlGF levels. Using a sFlt-1/PlGF ratio, we found significantly higher values of sFlt-1/PlGF in pregnancies complicated by IUGR. Our results confirm the findings of Stepan et al. [25] , who also observed elevated levels of sFlt-1 levels in pregnant women with isolated IUGR. Interestingly Shibata et al. [12] , as well as Wathen et al. [26] , were unable to detect elevated levels in normotensive women with SGA (small-for-gestationalage) babies. This controversy may be explained by the different populations studied: the mean gestational age of the SGA group was 39 [12] or 38 [26] weeks of pregnancy respectively. In the present study, the mean gestational age was 33 completed weeks, therefore indicating a more severe form of IUGR. Additionally Shibata et al. [12] defined SGA as a birth weight below the tenth centile and no other information, such as Doppler parameters, indicating the severity of the disease were given. Wathen et al. [26] defined IUGR as a birth weight below a certain percentile (two S.D. values below the national average at the particular gestational age). This definition is often combined with the term SGA and includes not only fetuses with IUGR due to placental insufficiency, but also fetuses with a lower genetic growth potential but which are otherwise healthy without malnutrition or hypoxia. Although we cannot rule out the possibility that the women with pregnancies complicated by IUGR in the present study may have developed pregnancy-induced hypertension or pre-eclampsia with ongoing pregnancy, we could not find any signs of hypertension or preeclampsia throughout pregnancy and in the postpartum period.
The significant reduction in maternal sKDR levels in women with pregnancies complicated by IUGR could be explained by the fact that sKDR is derived mostly from endothelial cells [27, 28] , which will be reduced in volume in the presence of shallow vasculogenesis and angiogenesis. As we have shown similar alterations in maternal sKDR level in pre-eclamptic pregnancies [29] , the decrease in sKDR through the reduction in endothelial cells becomes more apparent.
Unlike Hohlagschwandtner et al. [9] , who found increased levels of bFGF in hypertensive disorders in pregnancy, no differences in maternal bFGF levels in our IUGR group were observed, possibly indirectly confirming the diagnosis of isolated IUGR.
In contrast with maternal levels, results on fetal angiogenic growth factors are sparse, and no information is available on the complete family of VEGF-related growth factors in normal pregnancy and pregnancies complicated by IUGR. To our knowledge, this is the first study to describe fetal serum levels of sFlt-1 and sKDR in pregnancies with isolated IUGR.
Umbilical vein levels of PlGF were significantly reduced in IUGR. As with maternal serum, reduced PlGF could be explained by the diminished placental mass in IUGR as well as by increased sFlt-1, which binds PlGF causing it not to be detected by the assay. The parallel increases in maternal and umbilical vein sFlt-1 levels and decreases in PlGF and sKDR levels point to a placental origin of the alterations of these angiogenic factors. As there was no significant change in angiogenic growth factor levels in umbilical arteries, a fetal origin of the angiogenic imbalance in IUGR is unlikely.
Our observation of increased umbilical vein levels of bFGF in IUGR differs from that of Hill et al. [21] , who reported a trend towards decreased bFGF levels in IUGR. Since Hill et al. [21] included patients with fetal chromosomal abnormalities, altered bFGF levels might be due to these pathologies. We hypothesize that the increase in umbilical vein bFGF in IUGR could be caused by secretion via a non-classical pathway, such as cell death [30] , which appears to occur under hypoxic conditions such as IUGR [31] .
In controls, fetal PlGF and sFlt-1 levels from both the umbilical artery and vein were significantly reduced, and levels of VEGF were significantly increased, compared with the maternal compartment. Although lower levels were observed in IUGR, the difference in umbilical artery PlGF levels was not statistically significant. sKDR levels did not differ significantly between maternal and fetal compartments, nor were there differences in the sFlt-1/ PlGF ratio. Flt-1 and PlGF are produced mainly in the syncytial trophoblast, whereas VEGF is produced primarily in decidual and extravillous trophoblast cells [32, 33] . PlGF and sFlt-1 should be secreted predominantly into the maternal circulation, whereas VEGF could be secreted mainly into the fetal circulation. Moreover, the substantially higher level of sFlt-1 in the maternal compartment would remove free VEGF from the blood, causing levels of free VEGF to be extremely low.
Of note, in the control group, umbilical artery blood had greater concentrations of bFGF than maternal or umbilical vein blood. In IUGR, however, no significant differences were observed, although umbilical artery blood concentrations appeared to be greater than those in the maternal blood.
We speculate that the fetal reaction to the angiogenic imbalances in IUGR is the preferential perfusion of central organs in order to establish sufficient bFGF supply, necessary for neuronal, lung and blood vessel development [34] . Above a critical threshold level, bFGF could induce atherogenesis, as increased aortic wall thickness in growth-restricted newborns suggests [35] .
In summary, our results underline the potential of the placenta to release angiogenic factors into the maternal as well as fetal circulation, supporting a placental origin of the angiogenic imbalance in IUGR. Overproduction of sFlt-1 binds to VEGF and PlGF, reducing the levels of these factors. The fetus does not appear to metabolize these factors in significant amounts or contribute significantly to the pathophysiology of the disorder.
